Trial Outcomes & Findings for Clinical Outcomes of Lumbar Degenerative Disc Disease in Active-Duty U.S. Service Personnel (NCT NCT01028300)
NCT ID: NCT01028300
Last Updated: 2016-03-02
Results Overview
TERMINATED
NA
4 participants
24 months
2016-03-02
Participant Flow
Participant milestones
| Measure |
ProDisc L
ProDisc™-L Total Disc Replacement (TDR): The design is based on a ball and socket articulation, one surface being metal and the other an ultra-high molecular weight polyethylene (UHMWPE). Three components comprise this modular prosthesis.
|
|---|---|
|
Overall Study
STARTED
|
4
|
|
Overall Study
COMPLETED
|
0
|
|
Overall Study
NOT COMPLETED
|
4
|
Reasons for withdrawal
| Measure |
ProDisc L
ProDisc™-L Total Disc Replacement (TDR): The design is based on a ball and socket articulation, one surface being metal and the other an ultra-high molecular weight polyethylene (UHMWPE). Three components comprise this modular prosthesis.
|
|---|---|
|
Overall Study
Study Terminated
|
4
|
Baseline Characteristics
Clinical Outcomes of Lumbar Degenerative Disc Disease in Active-Duty U.S. Service Personnel
Baseline characteristics by cohort
| Measure |
ProDisc L
n=4 Participants
ProDisc™-L Total Disc Replacement (TDR): The design is based on a ball and socket articulation, one surface being metal and the other an ultra-high molecular weight polyethylene (UHMWPE). Three components comprise this modular prosthesis.
|
|---|---|
|
Age, Categorical
<=18 years
|
0 Participants
n=5 Participants
|
|
Age, Categorical
Between 18 and 65 years
|
4 Participants
n=5 Participants
|
|
Age, Categorical
>=65 years
|
0 Participants
n=5 Participants
|
|
Sex: Female, Male
Female
|
1 Participants
n=5 Participants
|
|
Sex: Female, Male
Male
|
3 Participants
n=5 Participants
|
|
Region of Enrollment
United States
|
4 participants
n=5 Participants
|
PRIMARY outcome
Timeframe: 24 monthsPopulation: Study was terminated early due to slow enrollment. 1 subject was enrolled but not treated due to study termination. 1 subject was enrolled and treated, but had no follow-up visits due to study termination. Only Two subjects were seen for follow-up visits, and only at 3 months post surgery.
Outcome measures
Outcome data not reported
SECONDARY outcome
Timeframe: 24 monthsPopulation: Study was terminated early due to slow enrollment. 1 subject was enrolled but not treated due to study termination. 1 subject was enrolled and treated, but had no follow-up visits due to study termination. Only Two subjects were seen for follow-up visits, and only at 3 months post surgery.
Outcome measures
Outcome data not reported
SECONDARY outcome
Timeframe: 24 monthsPopulation: Study was terminated early due to slow enrollment. 1 subject was enrolled but not treated due to study termination. 1 subject was enrolled and treated, but had no follow-up visits due to study termination. Only Two subjects were seen for follow-up visits, and only at 3 months post surgery.
Outcome measures
Outcome data not reported
SECONDARY outcome
Timeframe: 24 monthsPopulation: Study was terminated early due to slow enrollment. 1 subject was enrolled but not treated due to study termination. 1 subject was enrolled and treated, but had no follow-up visits due to study termination. Only Two subjects were seen for follow-up visits, and only at 3 months post surgery.
Outcome measures
Outcome data not reported
Adverse Events
ProDisc L
Serious adverse events
| Measure |
ProDisc L
n=4 participants at risk
ProDisc™-L Total Disc Replacement (TDR): The design is based on a ball and socket articulation, one surface being metal and the other an ultra-high molecular weight polyethylene (UHMWPE). Three components comprise this modular prosthesis.
|
|---|---|
|
Skin and subcutaneous tissue disorders
Non-infected seroma
|
25.0%
1/4 • Number of events 1 • 12 and 24 months
|
Other adverse events
| Measure |
ProDisc L
n=4 participants at risk
ProDisc™-L Total Disc Replacement (TDR): The design is based on a ball and socket articulation, one surface being metal and the other an ultra-high molecular weight polyethylene (UHMWPE). Three components comprise this modular prosthesis.
|
|---|---|
|
Musculoskeletal and connective tissue disorders
Back Pain
|
25.0%
1/4 • Number of events 1 • 12 and 24 months
|
|
Nervous system disorders
Paresthesia
|
25.0%
1/4 • Number of events 1 • 12 and 24 months
|
|
Gastrointestinal disorders
Emesis
|
25.0%
1/4 • Number of events 1 • 12 and 24 months
|
|
Gastrointestinal disorders
Pain-abdomen
|
25.0%
1/4 • Number of events 1 • 12 and 24 months
|
Additional Information
Results disclosure agreements
- Principal investigator is a sponsor employee Clinical Investigators may freely present or publish results of the Clinical Investigation in a manner which fairly sets forth the conclusions reached by the Clinical Investigators, but only after the Sponsor has been given the opportunity of reviewing the proposed presentation or publication prior to the intended submission, presentation, or publication date
- Publication restrictions are in place
Restriction type: OTHER